Open-label pilot study of injectable naltrexone for cannabis dependence

Open-label pilot study of injectable naltrexone for cannabis dependence

Background: There are no FDA-approved pharmacotherapies for cannabis use disorders (CUD), despite the evaluation of numerous medications. Notably, chronic dosing of oral naltrexone decreases self-administration of cannabis in human laboratory studies. Objectives: To test the feasibility of long-acti...

Full description

Bibliographic Details
Main Authors:	Brooks, D.J (Author), Choi, C.J (Author), Kelly, M.A (Author), Levin, F.R (Author), Mahony, A.L (Author), Mariani, J.J (Author), Notzon, D.P (Author), Pavlicova, M. (Author)
Format:	Article
Language:	English
Published:	Taylor and Francis Ltd 2018
Subjects:	adult Adult alcohol consumption anorexia anxiety disorder Article Cannabis cannabis addiction cannabis use chill clinical article clinical trial controlled study creatinine diaphoresis dizziness dronabinol drug efficacy drug safety dry heave DSM-IV-TR fatigue feasibility study female Female headache human Humans injection site irritation Injections, Intramuscular insomnia intramuscular drug administration irritability male Male marijuana Marijuana Abuse medication middle aged Middle Aged muscle weakness myalgia naltrexone Naltrexone narcotic antagonist Narcotic Antagonists nausea open study outcome assessment pilot Pilot Projects pilot study qualitative analysis sweat gland disease treatment treatment outcome Treatment Outcome urine level vivid dream vomiting
Online Access:	View Fulltext in Publisher

Similar Items

Leveraging user perspectives for insight into cannabis concentrates
by: Cahn, E.S, et al.
Published: (2018)

Proceedings of the 2021 Cannabis Clinical Outcomes Research Conference
by: Amie J. Goodin, et al.
Published: (2021-09-01)

Cambios a la normativa penal introducidos por la Ley de Regulación y Control del Mercado de la Marihuana aprobada en Uruguay
by: Diego Silva Forné
Published: (2017-06-01)

A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
by: Sebastian Jugl, et al.
Published: (2021-02-01)

Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management
by: Barrett, F.S, et al.
Published: (2018)

Intervenções farmacológica e psicossocial para os distúrbios por uso da cannabis Pharmacological and psychosocial interventions for cannabisuse disorders
by: Alan J. Budney, et al.
Published: (2010-05-01)

Improving police conceptual knowledge of Mexico's law on cannabis possession: Findings from an assessment of a police education program
by: Arredondo, J., et al.
Published: (2018)

Acute Myocardial Infarction following Naltrexone Consumption; a Case Report
by: Bita Dadpour, et al.
Published: (2016-12-01)

Popularity of marijuana among Polish students
by: Michał Pająk, et al.
Published: (2017-09-01)

Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management
by: Anderson, B.J, et al.
Published: (2018)

Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: Trivariate twin modelling and implications for genetic design
by: Agrawal, A., et al.
Published: (2018)

Thyroid Function of Former Opioid Addicts on Naltrexone Treatment
by: Ioannis Ilias, et al.
Published: (2001-01-01)

Die sintese van tetrahidrokannabinol analoë
by: Henning, Tjaart Johannes
Published: (2014)

Weighing the Benefits and Risks of Medical Marijuana Use: A Brief Review
by: Allison Karst
Published: (2018-12-01)

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
by: Anjali K. Bhardwaj, et al.
Published: (2018-05-01)

The Regulatory Transformation in Using Medicinal Cannabis to Treat Disease in the United States
by: Rubin, Kevin
Published: (2019)

Cannabis Cures: American Medicine, Mexican Marijuana, and the Origins of the War on Weed, 1840-1937
by: Rathge, Adam R.
Published: (2017)

Cannabis, medical use and related policies reflections on society (tur)
by: Ebru Aldemir, et al.
Published: (2020-04-01)

Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index
by: Marco H. Benedetti, et al.
Published: (2021-06-01)

Insights from individuals successfully recovered from cannabis use disorder: natural versus treatment-assisted recoveries and abstinent versus moderation outcomes
by: David C. Hodgins, et al.
Published: (2018-07-01)

Medical marijuana: A panacea or scourge
by: Surender Kashyap, et al.
Published: (2014-01-01)

The New Runner's High? Examining Relationships Between Cannabis Use and Exercise Behavior in States With Legalized Cannabis
by: Sophie L. YorkWilliams, et al.
Published: (2019-04-01)

Medical Cannabis for Older Patients—Treatment Protocol and Initial Results
by: Ran Abuhasira, et al.
Published: (2019-11-01)

Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization
by: Bahorik, A.L, et al.
Published: (2018)

International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis
by: Anees Bahji, et al.
Published: (2019-08-01)

Cannabis as a substitute for prescription drugs – a cross-sectional study
by: Corroon Jr JM, et al.
Published: (2017-05-01)

Conceptual and methodologic challenges of assessing the short-term efficacy of Guggulu in obesity: data emergent from a naturalistic clinical trial.
by: Bhatt A, et al.
Published: (1995-01-01)

The cannabis withdrawal syndrome: current insights
by: Bonnet U, et al.
Published: (2017-04-01)

Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study
by: Kathleen Gali, et al.
Published: (2021-02-01)

Personal Correlates of Support for Medical and Recreational Cannabis Legalization in Australia
by: Vivian Chiu, et al.
Published: (2021-02-01)

State marijuana laws and opioid overdose mortality
by: Stanford Chihuri, et al.
Published: (2019-09-01)

Fumaça na nuvem: a busca por \'maconha\' no Google e no Facebook
by: Marina Lang
Published: (2016)

Fumaça na nuvem: a busca por \'maconha\' no Google e no Facebook
by: Lang, Marina
Published: (2016)

Assessment of the Association of Cannabis on Female Sexual Function With the Female Sexual Function Index
by: Alex M. Kasman, MD, MS, et al.
Published: (2020-12-01)

The role of social isolation in opioid addiction
by: Christie, N.C
Published: (2021)

Academic migration and marijuana use among undergraduate students: evidences from a sample in southern Brazil
by: Lauro Miranda Demenech, et al.

Legalising Drugs Prudently: The Importance of Incentives and Values
by: Jonathan Caulkins
Published: (2019-11-01)

American Weed: A History of Cannabis Cultivation in the United States
by: Nick Johnson
Published: (2019-07-01)

An emerging allergen: Cannabis sativa allergy in a climate of recent legalization
by: Bradley Jackson, et al.
Published: (2020-06-01)

Legalization of cannabis in Canada
by: Gligorijević Nemanja
Published: (2020-01-01)